Alpha Tau Medical (DRTS) Cash & Current Investments (2020 - 2026)

Alpha Tau Medical has reported Cash & Current Investments for 7 years, with the latest figure at $76.4 million in Q1 2026.

• Quarterly Cash & Current Investments rose 48.0% year-over-year to $76.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $76.4 million (up 48.0% YoY) and the FY2025 annual result came in at $73.1 million, up 22.69% from the prior year.
• Cash & Current Investments advanced to $76.4 million in Q1 2026 per DRTS's latest filing, from $73.1 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $8.2 billion in Q1 2022 and troughed at $51.6 million in Q1 2025.
• A 5-year average of $559.1 million and a median of $79.7 million in 2025 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments jumped 68881.88% in 2022, then slumped 98.78% in 2023.
• Over 5 years, Cash & Current Investments stood at $104.5 million in 2022, then fell by 21.76% to $81.8 million in 2023, then fell by 27.13% to $59.6 million in 2024, then advanced by 22.69% to $73.1 million in 2025, then rose by 4.5% to $76.4 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $76.4 million, $73.1 million, and $72.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.